Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease-Reference-Cited by-同舟云学术

Comparison of Interim PET Response to Second-Line Versus First-Line Treatment in Classic Hodgkin Lymphoma: Contribution to the Development of Response Criteria for Relapsed or Progressive Disease

Published:2020-08-06 Issue:3 Volume:62 Page:338-341
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Kluge Regine,Wittig Tim,Georgi Thomas W.,Kurch Lars,Sabri Osama,Wallace W. Hamish,Klekawka Tomasz,Fernández-Teijeiro Ana,Ceppi Francesco,Karlén Jonas,Pears Jane,Cepelová Michaela,Fosså Alexander,Beishuizen Auke,Hjalgrim Lisa Lyngsie,Körholz Dieter,Mauz-Körholz Christine,Hasenclever Dirk

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference21 articles.

1. Interim FDG-PET imaging in lymphoma;Gallamini;Semin Nucl Med.,2018

2. FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas

3. Hodgkin lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Eichenauer;Ann Oncol.,2018

4. Current role of FDG-PET in pediatric Hodgkin’s lymphoma;Kluge;Semin Nucl Med.,2017

5. PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin study group;Borchmann;Lancet.,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on FDG-PET in pediatric lymphoma;The Quarterly Journal of Nuclear Medicine and Molecular Imaging;2024-04

2. Fluorodeoxyglucose-Positron Emission Tomography in Relapsed/Refractory Hodgkin Lymphoma: A Practical Approach;Chemotherapy;2023-09-14

3. The Impact of PET/CT on Paediatric Oncology;Diagnostics;2023-01-05

4. 18F-FDG PET/CT prognostic role in predicting response to salvage therapy in relapsed/refractory Hodgkin's lymphoma;Clinical Imaging;2022-12

5. Imaging recommendations in pediatric lymphoma: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper;Pediatric Blood & Cancer;2022-09-16